BackgroundCheck.run
Search For

Darren Lyle Bates, 468933 Falls Farm Dr, Potomac, MD 20854

Darren Bates Phones & Addresses

Potomac, MD   

5243 Via Capote, Newbury Park, CA 91320   

Westlake Village, CA   

Oak Park, CA   

2616 Olive St, Cedar Falls, IA 50613    319-2777758   

2106 Yorkshire Dr, Cedar Falls, IA 50613    319-2776857   

Mountain View, CA   

Walnut Creek, CA   

Boulder, CO   

Mentions for Darren Lyle Bates

Darren Bates resumes & CV records

Resumes

Darren Bates Photo 35

Nationally Recognized Disability Employment Expert And Thought Leader In Global Diversity And Inclusion Strategies

Position:
National Workforce Strategist at National Disability Institute, Founder & President at Employment Alliance for People with Disabilities (EAPD), Chairman & CEO at Darren Bates LLC
Location:
Washington D.C. Metro Area
Industry:
Nonprofit Organization Management
Work:
National Disability Institute - Washington D.C. Metro Area since May 2013
National Workforce Strategist
Employment Alliance for People with Disabilities (EAPD) since 2010
Founder & President
Darren Bates LLC since 2012
Chairman & CEO
Awards:
Lex Frieden Employment Award -Martha Arbuckle Category
Texas Governor's Committee on Persons with Disabilites
Awarded to the SINGLE most innovative committee and project in the state of Texas that has transformed the lives of job seekers with disabilities.
Outstanding Partner of the Year
Texas Department of Assistive and Rehabilitative Services
Awarded to the most outstanding partner and collaborator of the year that has helps the Texas Department of Assistive and Rehabilitative Services enhance the empowerment and employment of Texas with disabilities.
Certifications:
Certified Workforce Development Expert, National Workforce Institute
Darren Bates Photo 36

Principal Scientist

Location:
5243 Via Capote, Newbury Park, CA 91320
Industry:
Biotechnology
Work:
Amgen
Principal Scientist
Amgen
Senior Scientist
Stanford University School of Medicine Aug 2008 - Apr 2011
Postdoctoral Fellow
University of Colorado Boulder Aug 2001 - Aug 2007
Graduate Student
Education:
University of Colorado Boulder 2001 - 2007
Doctorates, Doctor of Philosophy, Chemistry
University of Northern Iowa 1997 - 2001
Bachelors, Bachelor of Science, Chemistry
Skills:
Molecular Cloning, Biotechnology, Antibodies, Cell Culture, Drug Discovery, Biochemistry, Assay Development, Cell Biology
Languages:
English
Darren Bates Photo 37

Darren Bates

Publications & IP owners

Us Patents

Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (Gipr) In Combination With Glp-1 Agonists

US Patent:
2019027, Sep 12, 2019
Filed:
Feb 25, 2019
Appl. No.:
16/285118
Inventors:
- Thousand Oaks CA, US
Donghui Shi - Thousand Oaks CA, US
David J. Lloyd - Thousand Oaks CA, US
Jinghong Wang - Palo Alto CA, US
Renee Komorowski - Ventura CA, US
Neeraj Agrawal - Thousand Oaks CA, US
Darren L. Bates - Oak Park CA, US
Brandon C. P. Clavette - Coquitlam, CA
Ian N. Foltz - Burnaby, CA
Shu-yin Ho - Thousand Oaks CA, US
Christopher Murawsky - Roberts Creek, CA
Xiaoshan Min - Burlingame CA, US
Zhulun Wang - Palo Alto CA, US
Assignee:
AMGEN INC. - THOUSAND OAKS CA
International Classification:
C07K 16/28
A61K 9/00
A61K 38/26
A61K 39/395
A61K 38/17
Abstract:
Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the antigen binding protein is administered in combination with a GLP-1 receptor agonist.

Interleukin-21 Muteins And Methods Of Treatment

US Patent:
2019004, Feb 14, 2019
Filed:
Aug 3, 2018
Appl. No.:
16/054035
Inventors:
- Thousand Oaks CA, US
Neeraj Jagdish Agrawal - Newbury Park CA, US
Gunasekaran Kannan - Thousand Oaks CA, US
Ian Foltz - Thousand Oaks CA, US
Zhulun Wang - Thousand Oaks CA, US
Darren Bates - Thousand Oaks CA, US
Marissa Mock - Thousand Oaks CA, US
Shunsuke Takenaka - Thousand Oaks CA, US
International Classification:
A61K 38/20
A61P 35/00
C12N 15/63
C07K 16/28
Abstract:
Provided herein are IL-21 muteins and fusion proteins comprising the same for use in methods of treating a disease. Related conjugates, nucleic acids, vectors, host cells, pharmaceutical compositions and kits are also provided herein. Methods of making the IL-21 muteins and fusion proteins comprising the same, as well as methods of treating a subject in need thereof, are provided by the present disclosure. Further provided are PD-1 antigen-binding proteins.

Superkines And Synthekines: Repurposed Cytokines With New And Enhanced Signaling Activities

US Patent:
2018001, Jan 18, 2018
Filed:
Jul 27, 2017
Appl. No.:
15/662180
Inventors:
- Stanford CA, US
Darren L. Bates - Oak Park CA, US
Ignacio Moraga - Palo Alto CA, US
International Classification:
C07K 14/54
C07K 14/52
A61K 38/00
Abstract:
Disclosed herein are IL-4 cytokine compositions with enhanced biological activity having increased selectivity for IL-4 cytokine receptors, and methods for their use. These compositions encompass interleukin-4 (IL-4) muteins. The disclosed methods encompass administering an IL-4 to treat neoplastic diseases, autoimmune diseases, infectious diseases or for expanding a hematopoietic cell population.

Method Of Treating Or Ameliorating Metabolic Disorders Using Binding Proteins For Gastric Inhibitory Peptide Receptor (Gipr) In Combination With Glp-1 Agonists

US Patent:
2017027, Sep 28, 2017
Filed:
Dec 21, 2016
Appl. No.:
15/387542
Inventors:
- THOUSAND OAKS CA, US
Donghui SHI - Thousand Oaks CA, US
David J. LLOYD - Thousand Oaks CA, US
Jinghong WANG - Palo Alto CA, US
Renee KOMOROWSKI - Ventura CA, US
Neeraj AGRAWAL - Thousand Oaks CA, US
Darren L. BATES - Oak Park CA, US
Brandon C. P. CLAVETTE - Coquitlam, CA
Ian N. FOLTZ - Burnaby, CA
Shu-yin HO - Thousand Oaks CA, US
Christopher MURAWSKY - Roberts Creek, CA
Xiaoshan MIN - Burlingame CA, US
Zhulun WANG - Palo Alto CA, US
Assignee:
AMGEN INC. - THOUSAND OAKS CA
International Classification:
C07K 16/28
A61K 39/395
A61K 38/26
A61K 9/00
Abstract:
Methods of treating metabolic diseases and disorders using an antigen binding protein specific for the GIPR polypeptide are provided. In various embodiments the metabolic disease or disorder is type 2 diabetes, obesity, dyslipidemia, elevated glucose levels, elevated insulin levels and diabetic nephropathy. In certain embodiments the antigen binding protein is administered in combination with a GLP-1 receptor agonist.

Superkines And Synthekines: Repurposed Cytokines With New And Enhanced Signaling Activities

US Patent:
2016024, Aug 25, 2016
Filed:
Aug 8, 2013
Appl. No.:
14/419873
Inventors:
K. Christopher GARCIA - Ann Arbor MI, US
Darren L. BATES - Oak Park CA, US
Ignacio MORAGA - Palo Alto CA, US
International Classification:
C07K 14/54
Abstract:
Disclosed herein are IL-4 cytokine compositions with enhanced biological activity having increased selectivity for IL-4 cytokine receptors, and methods for their use. These compositions encompass interleukin-4 (IL-4) muteins. The disclosed methods encompass administering an IL-4 to treat neoplastic diseases, autoimmune diseases, infectious diseases or for expanding a hematopoietic cell population.

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.